As the Senior Director of IT R&D at Crinetics Pharmaceuticals, John Savage plays a pivotal role in bridging the gap between technology and regulatory compliance in the pharmaceutical industry. With a deep understanding of the complexities inherent in FDA-regulated environments, he is adept at navigating...
As the Senior Director of IT R&D at Crinetics Pharmaceuticals, John Savage plays a pivotal role in bridging the gap between technology and regulatory compliance in the pharmaceutical industry. With a deep understanding of the complexities inherent in FDA-regulated environments, he is adept at navigating the intricate landscape of research and development through to commercialization. John’s extensive experience across various IT disciplines enables him to implement innovative solutions that enhance operational efficiency and drive strategic initiatives.
Currently, John is spearheading several key projects aimed at aligning Crinetics' systems and business processes with the stringent requirements of New Drug Applications (NDA) and Health Authority (HA) inspections. His strategic planning skills are critical as he collaborates with cross-functional teams to ensure that all internal support resources and strategic partners are effectively coordinated. This alignment not only streamlines workflows but also mitigates risks associated with compliance and documentation, which are vital in the pharmaceutical sector.
John’s expertise in Laboratory Information Management Systems (LIMS) and Clinical Trial Management Systems (CTMS) positions him as a trusted advisor in the implementation of technology solutions that support medical device development and regulatory submissions. His strong negotiation skills and experience in change management facilitate productive vendor partnerships, ensuring that Crinetics can leverage external resources to enhance its R&D capabilities. By fostering a culture of collaboration and continuous improvement, John is committed to delivering meaningful enhancements that create lasting value for the company and its stakeholders.
![Kelly Kingera ([email protected])](https://find.refinehq.ai/wp-content/uploads/2025/07/Kelly-Kingera-email-protected-profile.jpg)
